You can buy or sell NuCana and other stocks, options, ETFs, and crypto commission-free!
NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology consists of acelarin, NUC-3373 and NUC-7738. Read More The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.
52 Week High
52 Week Low
— per share
Expected May 12, After Hours